Skip to main content

Expert Insights

First Report Managed Care
Several states are pursuing alternative payment models for prescription drugs to curb spending and address public health crises, but experts say these new strategies face a variety of challenges on their way to implementation.
Integrated Healthcare Executive
Chad Peterson, vice president of public sector solutions, and Sean Donoghue, senior vice president, both at Orion Health, discuss the next generation of HIEs and highlight why HIEs are beneficial in integrated health care systems.
Population Health Learning Network
Nicole Rochester, MD, CEO, Your GPS Doc, LLC, George Washington University School of Medicine, discusses the importance of strong connections between patients, caregivers, and their health team, as well as shares her personal experiences as a caregiver.
Population Health Learning Network
Nicki Andrews, MPH, project manager at Primary Care Development Corporation, outlines the successes of integrating the Collaborative Care Impact Model in a variety of primary care settings.
Population Health Learning Network
Lori Francis, MBA, PCMH CCE, a program management specialist at BlueCross BlueShield recently presented at Health Care Quality Congress 2019 in Dallas, Texas, on the benefits of using embedded care coordinators to improve physician and payer partnerships.
Pharmacy Learning Network
Mark Munger, PharmD, discusses recent study findings, which show that ranolazine increases the adverse effect profile of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, raising concern for patient safety.
Veterans Health Today
Catherine Chanfreau-Coffinier, PhD, explains how pharmacogenetic testing would impact a large proportion of veterans if it was implemented in the VA population.
First Report Managed Care
Gary Owens, MD, president of Gary Owens Associates, shares a payer perspective on treatment options for chronic lymphocytic leukemia, and weighs the benefits and challenges of using targeted therapy with ibrutinib compared with traditional chemoimmunotherapy.
Pharmacy Learning Network
Ann Latner, JD, discusses an issue that is arising more frequently, and explains why it is important for pharmacists to understand what constitutes slander or defamation, and what doesn’t.
Pharmacy Learning Network
Michael Cawley, PharmD, discusses challenges that community pharmacies face and highlights initiatives that help pharmacists implement change and improve patient care.
Back to Top